30045 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Sep 09
00:56 UTC
|
RRC
Range Resources
|
◎ Target | Betty Jiang ★★☆☆☆ #2638 | Equal Weight | $40.00→ $42.00+5.0% |
|
Sep 09
00:56 UTC
|
RPRX
Royalty Pharma
|
◎ Target | Michael Nedelcovych ★★★☆☆ #1700 | Buy | $65.00→ $68.00+4.6% |
|
Sep 09
00:56 UTC
|
ROIV
Roivant Sciences
|
◎ Target | Dennis Ding ★★★☆☆ #1775 | Buy | $42.00→ $52.00+23.8% |
|
Sep 09
00:56 UTC
|
ROIV
Roivant Sciences
|
◎ Target | Douglas Tsao ★★☆☆☆ #2342 | Buy | $41.00→ $47.00+14.6% |
|
Sep 09
00:56 UTC
|
RF
Regions Financial
|
◎ Target | Betsy Graseck not yet tracked | Equal Weight | $35.00→ $36.00+2.9% |
|
Sep 09
00:56 UTC
|
PTON
Peloton Interactive
|
◎ Target | Arpine Kocharyan ★★★☆☆ #2175 | Buy | $11.00→ $10.00-9.1% |
|
Sep 09
00:56 UTC
|
PSX
Phillips 66
|
◎ Target | Manav Gupta ★★★★☆ #645 | Buy | $235.00→ $300.00+27.7% |
|
Sep 09
00:56 UTC
|
PGNY
Progyny
|
◎ Target | Constantine Davides ★★☆☆☆ #2369 | Market Outperform | $31.00→ $33.00+6.5% |
|
Sep 09
00:56 UTC
|
ONTO
Onto Innovation
|
◎ Target | Shane Brett not yet tracked | Overweight | $383.00→ $360.00-6.0% |
|
Sep 09
00:56 UTC
|
NOW
ServiceNow
|
◎ Target | Allan Verkhovski ★★★☆☆ #1349 | Buy | $150.00→ $170.00+13.3% |
|
Sep 09
00:56 UTC
|
NOC
Northrop Grumman
|
◎ Target | Gavin Parsons ★★★☆☆ #1990 | Buy | $685.00→ $704.00+2.8% |
|
Sep 09
00:56 UTC
|
MSTR
Strategy
|
◎ Target | Joseph Vafi ★★★☆☆ #1537 | Buy | $175.00→ $179.00+2.3% |
|
Sep 09
00:56 UTC
|
MRK
Merck & Co., Inc.
|
◎ Target | Vamil Divan ★★☆☆☆ #2368 | Buy | $146.00→ $170.00+16.4% |
|
Sep 09
00:56 UTC
|
MPC
Marathon Petroleum
|
◎ Target | Manav Gupta ★★★★☆ #645 | Buy | $321.00→ $450.00+40.2% |
|
Sep 09
00:56 UTC
|
MANH
Manhattan Associates
|
◎ Target | Guy Hardwick ★★★☆☆ #1561 | Overweight | $201.00→ $239.00+18.9% |
|
Sep 09
00:56 UTC
|
MAA
Mid-America Apartment Communities
|
◎ Target | Haendel St. Juste ★★★☆☆ #1768 | Outperform | $152.00→ $140.00-7.9% |
|
Sep 09
00:56 UTC
|
JBL
Jabil
|
◎ Target | Mark Delaney ★★★☆☆ #1500 | Buy | $482.00→ $375.00-22.2% |
|
Sep 09
00:56 UTC
|
IRM
Iron Mountain
|
◎ Target | Brendan Lynch ★★★☆☆ #1465 | Overweight | $143.00→ $144.00+0.7% |
|
Sep 09
00:56 UTC
|
IONS
Ionis Pharmaceuticals
|
◎ Target | Salveen Richter ★★★☆☆ #1770 | Neutral | $69.00→ $56.00-18.8% |
|
Sep 09
00:56 UTC
|
IONS
Ionis Pharmaceuticals
|
◎ Target | Michael Ulz ★☆☆☆☆ #2894 | Overweight | $110.00→ $104.00-5.5% |
|
Sep 09
00:56 UTC
|
IONS
Ionis Pharmaceuticals
|
◎ Target | Mitchell S. Kapoor not yet tracked | Buy | $115.00→ $100.00-13.0% |
|
Sep 09
00:56 UTC
|
IONS
Ionis Pharmaceuticals
|
◎ Target | Gary Nachman ★★☆☆☆ #2715 | Buy | $95.00→ $85.00-10.5% |
|
Sep 09
00:56 UTC
|
HYPD
Hyperion DeFi
|
◎ Target | James McIlree ★☆☆☆☆ #2948 | Buy | $7.30→ $8.45+15.8% |
|
Sep 09
00:56 UTC
|
HOOD
Robinhood Markets
|
◎ Target | Ramsey El-Assal not yet tracked | Overweight | $115.00→ $150.00+30.4% |
|
Sep 09
00:56 UTC
|
HOOD
Robinhood Markets
|
◎ Target | James Yaro ★★★☆☆ #2238 | Buy | $124.00→ $142.00+14.5% |
|
Sep 09
00:56 UTC
|
HOOD
Robinhood Markets
|
◎ Target | Daniel Fannon ★★★★★ #292 | Buy | $127.00→ $140.00+10.2% |
|
Sep 09
00:56 UTC
|
HOG
Harley-Davidson
|
◎ Target | James Hardiman ★★★☆☆ #2108 | Neutral | $27.00→ $31.00+14.8% |
|
Sep 09
00:56 UTC
|
HNGE
Hinge Health
|
◎ Target | David Grossman ★★★☆☆ #1435 | Buy | $96.00→ $115.00+19.8% |
|
Sep 09
00:56 UTC
|
GD
General Dynamics
|
◎ Target | Gavin Parsons ★★★☆☆ #1990 | Neutral | $395.00→ $408.00+3.3% |
|
Sep 09
00:56 UTC
|
FSJ
James Fisher and Sons
|
◎ Target | firm only | Buy | GBX 850→ GBX 835-1.8% |
|
Sep 09
00:56 UTC
|
FDX
FedEx
|
◎ Target | Brian Ossenbeck ★★★☆☆ #1956 | Overweight | $460.00→ $400.00-13.0% |
|
Sep 09
00:56 UTC
|
FDS
FactSet Research Systems
|
◎ Target | Manav Patnaik ★★★☆☆ #2026 | Underweight | $216.00→ $250.00+15.7% |
|
Sep 09
00:56 UTC
|
ETSY
Etsy
|
◎ Target | Taylor Conrad ★★☆☆☆ #2322 | Buy | $67.00→ $89.00+32.8% |
|
Sep 09
00:56 UTC
|
EQIX
Equinix
|
◎ Target | Brendan Lynch ★★★☆☆ #1465 | Equal Weight | $1,130.00→ $1,135.00+0.4% |
|
Sep 09
00:56 UTC
|
EQBK
Equity Bancshares
|
◎ Target | Nathan Race ★★★★☆ #845 | Overweight | $58.00→ $60.00+3.4% |
|
Sep 09
00:56 UTC
|
EGAN
eGain
|
◎ Target | Erik Suppiger ★★☆☆☆ #2542 | Neutral | $10.50→ $6.00-42.9% |
|
Sep 09
00:56 UTC
|
DOO
BRP
|
◎ Target | James Hardiman ★★★☆☆ #2108 | Buy | $74.00→ $77.00+4.1% |
|
Sep 09
00:56 UTC
|
DOO
BRP
|
◎ Target | firm only | Buy | C$106.00→ C$110.00+3.8% |
|
Sep 09
00:56 UTC
|
DKNG
DraftKings
|
◎ Target | Jordan Bender ★★★☆☆ #1738 | Market Outperform | $36.00→ $37.00+2.8% |
|
Sep 09
00:56 UTC
|
DINO
HF Sinclair
|
◎ Target | Manav Gupta ★★★★☆ #645 | Buy | $105.00→ $126.00+20.0% |
|
Sep 09
00:56 UTC
|
DGX
Quest Diagnostics
|
◎ Target | Kevin Caliendo ★★★☆☆ #1276 | Neutral | $232.00→ $245.00+5.6% |
|
Sep 09
00:56 UTC
|
DG
Dollar General
|
◎ Target | Seth Sigman ★★★☆☆ #1983 | Overweight | $148.00→ $151.00+2.0% |
|
Sep 09
00:56 UTC
|
CPT
Camden Property Trust
|
◎ Target | Vikram Malhorta not yet tracked | Outperform | $125.00→ $116.00-7.2% |
|
Sep 09
00:56 UTC
|
CMS
CMS Energy
|
◎ Target | James Thalacker ★★★☆☆ #1657 | Outperform | $82.00→ $77.00-6.1% |
|
Sep 09
00:56 UTC
|
CLYM
Climb Bio
|
◎ Target | Raghuram Selvaraju not yet tracked | Buy | $24.00→ $30.00+25.0% |
|
Sep 09
00:56 UTC
|
CLYM
Climb Bio
|
◎ Target | Leland Gershell ★★★☆☆ #1119 | Outperform | $18.00→ $25.00+38.9% |
|
Sep 09
00:56 UTC
|
CDW
CDW
|
◎ Target | Tim Long ★★★☆☆ #1614 | Equal Weight | $123.00→ $150.00+22.0% |
|
Sep 09
00:56 UTC
|
BBOX
Tritax Big Box REIT
|
◎ Target | firm only | Buy | GBX 196→ GBX 188-4.1% |
|
Sep 09
00:56 UTC
|
APP
AppLovin
|
◎ Target | Clark Lampen ★★★★☆ #738 | Buy | $408.00→ $396.00-2.9% |
|
Sep 09
00:56 UTC
|
ALNY
Alnylam Pharmaceuticals
|
◎ Target | Faisal Khurshid ★★★★★ #62 | Hold | $230.00→ $260.00+13.0% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.